625 Flormann St, Rapid City, SD 57701
For Sale
1 / 3
This exceptional Class A, 5,527 square foot medical office building presents a compelling net lease investment opportunity in Rapid City, South Dakota. Located in the city's medical corridor at 625 Flormann St, 57701, this single-tenant property boasts a strong occupancy rate of 100% with a lease expiring May 31, 2025. The tenant, a subsidiary of QuickMD, acquired the business in March 2024 and has five, five-year renewal options, ensuring long-term stability. The building, constructed in 2001 and extensively renovated in 2019 and 2023, features four large offices, four consultation rooms, three restrooms, a breakroom/kitchenette, and a 1,495 square foot renovated basement providing additional workspace. Ample parking is available with 20 spaces, supplemented by four former drive-thru lanes. The property sits on a 0.56-acre lot and includes key card entry and building-wide security. Unique features include a fully functional vault, a legacy from its previous use as a bank. The property is zoned for general commercial use and offers a compelling return on investment with a current monthly net rent of $7,333.33. This is a turnkey investment opportunity with a proven tenant and significant upside potential.
-
Sarah Schryvers Physician
-
Dr. Kendra Joswiak Physician
-
C U Mortgage Direct Loan Service Bank
-
Project Recovery Medical Clinic
-
Michelle Wasson Physician
Cap rate
Implied · in-place · derived from last sale + estimated NOIValue
AI, CAP & Alternative Use estimations · Realmo proprietary blendProperty tax & assessments
Tax year 2023Comparables
6 recent transactions · within 1.5 miComparable in this City
Similar Nearby for Sale
Similar Nearby for Lease
Property description
Physical attributes from public recordsZoning & alternative use
No recorded transactions found for this property.
Costs & Benchmarks
Operating expenses, capex projections, utility benchmarks, and submarket comparables — all in one view.
Risks
Flood, climate, environmental, title, and tenant-concentration risk — surfaced with mitigations and source citations.